Johnson & Johnson Stock News

12 expected dividend increases in April 2024. Dividend growth is crucial for reaching financial freedom and combating high inflation.

The year 2023 was crucial in the Artificial Intelligence (AI) industry. So far this year, we have seen Apple's efforts to join the AI race more prudently, Amazon's billion dollar investment in AI star

Teva Pharmaceutical and Viatris convinced a U.S. appeals court on Monday to revive their challenges to a patent covering a blockbuster Johnson & Johnson schizophrenia drug, giving them a new chance to

Procter & Gamble, Johnson & Johnson Among 10 Dividend Growth Companies Announcing Increases In First Half Of April

Now that it's focused on just medical technology and pharmaceuticals, Johnson & Johnson's pace of annual dividend raises could accelerate. Medtronic is the largest publicly traded medical device manuf

Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.

Johnson & Johnson settles a consumer protection lawsuit for $75 million, a significant reduction from the initial demand of $6 billion. The company is facing nearly 60,000 lawsuits from ex-talc users

If you've been following the headlines, you'll be well aware of the value behind value stocks to buy. Basically, the smart money sees some risks ahead and they're adopting a more prudent approach.

Wall Street is poised to conclude the first quarter with robust gains due to a likely dovish Fed and robust economic as well as earnings growth.

The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.

Shockwave Medical shares are trading more than 3% higher in Wednesday's session, having soared more than 10% since it was announced Johnson & Johnson (NYSE:JNJ) was considering buying it. The maker of

The Dow Jones Industrial Average recently made new all-time highs, reaching a peak of 39,889. This has set off great excitement, with 40,000 seeming imminent and the possibility of Dow 50,000 starting

In the latest trading session, Johnson & Johnson (JNJ) closed at $155.77, marking a +0.35% move from the previous day.

Shares of medical-device maker Shockwave Medical Inc. rose Tuesday following a report that Johnson & Johnson was in talks to acquire the company.

Johnson & Johnson is in talks to buy medical device maker Shockwave Medical , the Wall Street Journal reported on Tuesday.